These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24359609)

  • 61. Nucleocytoplasmic Cdk5 is involved in neuronal cell cycle and death in post-mitotic neurons.
    Zhang J; Herrup K
    Cell Cycle; 2011 Apr; 10(8):1208-14. PubMed ID: 21415596
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity.
    Neubert JK; Widmer CG; Malphurs W; Rossi HL; Vierck CJ; Caudle RM
    Pain; 2005 Aug; 116(3):386-395. PubMed ID: 15982812
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
    Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
    J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
    Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
    Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
    Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
    Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cyclin-dependent kinase 5 is required for normal cerebellar development.
    Kumazawa A; Mita N; Hirasawa M; Adachi T; Suzuki H; Shafeghat N; Kulkarni AB; Mikoshiba K; Inoue T; Ohshima T
    Mol Cell Neurosci; 2013 Jan; 52():97-105. PubMed ID: 23085039
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.
    Demelash A; Rudrabhatla P; Pant HC; Wang X; Amin ND; McWhite CD; Naizhen X; Linnoila RI
    Mol Biol Cell; 2012 Aug; 23(15):2856-66. PubMed ID: 22696682
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Contribution and interaction of kinin receptors and dynorphin A in a model of trigeminal neuropathic pain in mice.
    Luiz AP; Schroeder SD; Rae GA; Calixto JB; Chichorro JG
    Neuroscience; 2015 Aug; 300():189-200. PubMed ID: 25982562
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phosphorylation of TRPV1 by cyclin-dependent kinase 5 promotes TRPV1 surface localization, leading to inflammatory thermal hyperalgesia.
    Liu J; Du J; Yang Y; Wang Y
    Exp Neurol; 2015 Nov; 273():253-62. PubMed ID: 26376215
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Involvement of nNOS in the antinociceptive activity of melatonin in inflammatory pain at the level of sensory neurons.
    Xie SS; Fan WG; Liu Q; Li JZ; Zheng MM; He HW; Huang F
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7399-7411. PubMed ID: 32706079
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
    Zhang Y; Li H; Hao J; Zhou Y; Liu W
    Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons.
    Morabito MA; Sheng M; Tsai LH
    J Neurosci; 2004 Jan; 24(4):865-76. PubMed ID: 14749431
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability.
    Moy LY; Tsai LH
    J Biol Chem; 2004 Dec; 279(52):54487-93. PubMed ID: 15471880
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cdk12 and Cdk13 regulate axonal elongation through a common signaling pathway that modulates Cdk5 expression.
    Chen HR; Lin GT; Huang CK; Fann MJ
    Exp Neurol; 2014 Nov; 261():10-21. PubMed ID: 24999027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3.
    Li BS; Zhang L; Takahashi S; Ma W; Jaffe H; Kulkarni AB; Pant HC
    EMBO J; 2002 Feb; 21(3):324-33. PubMed ID: 11823425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
    Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
    J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
    Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S
    Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.
    Sahin B; Hawasli AH; Greene RW; Molkentin JD; Bibb JA
    Eur J Pharmacol; 2008 Mar; 581(3):270-5. PubMed ID: 18190909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.